BiotechTube
Home/Cabaletta Bio/Catherine Bollard, M.D.
CB

Catherine Bollard, M.D.

Independent Director

Cabaletta Bio

Therapeutic Areas

Autoimmune DiseasesRheumatologyDermatologyNeurology

Cabaletta Bio Pipeline

DrugIndicationPhase
rese-cel (resecabtagene autoleucel)Systemic Lupus Erythematosus (SLE)Phase 1/2

Leadership Team at Cabaletta Bio

SN
Steven Nichtberger, M.D.
President, Chief Executive Officer, and Co-Founder
SB
Samik Basu, M.D.
Chief Scientific Officer
GB
Gwendolyn Binder, Ph.D.
President, Science & Technology
View full Cabaletta Bio profile